ARCHIVES

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

This article is from The Cancer Letter archive.

Vol. 04 No. 34 | August 25, 1978

Download PDF Visit The Full Archive

Related Articles

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

July 31, 2009

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

August 18, 1989

NCI Advisory Group, Other Cancer Meetings

July 29, 1983

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

Obituary: Daniel Nathans, 71, Won Nobel For Use of Restriction Enzyme

November 19, 1999

FDA News: Tentative Approval Given IVAX Paxene; BMS Exclusivity Upheld

January 9, 1998